Abstract
To assess better the link between congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis (CF), we compared sweat chloride values, analysis of the CFTR intron 8 poly(T) tract length and analysis of 10 exons in a population of 38 patients with CBAVD. The data indicate that this population can be divided into three groups of patients. In the first group of 15 patients with abnormal sweat chloride (> 60 mmol/l), the frequency of CF mutations is high. In the second group of 18 patients with equivocal sweat chloride (between 40 and 60 mmol/l), the frequency of the 5T variant is high; 6 patients have a ΔF508 mutation and a 5T variant and 1 patient is homozygous for the 5T variant; a 5T variant has been detected in 3 other patients, and a ΔF508 mutation in another patient. A third group of 5 patients is probably not related to CF: these patients have other congenital abnormalities of the urogenital tract, low chloride values (< 40 mmol/l) and apparently no abnormality of the CF gene.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anguiano A, Oates RD, Amos JA, Dean M, Gerrard B, Stewart C, Maher TA, White MB, Milunsky A (1992) Congenital absence of the vas deferens — a primarily genital form of cystic fibrosis. JAMA 267: 1794–1797
Augarten A, Yahav Y, Kerem BS, Halle D, Laufer J, Szeinberg A, Dor J, Mashiach S, Gazit E, Madgar I (1994) Congenital absence of vas deferens in the absence of cystic fibrosis. Lancet 344: 1473–1474
Bienvenu T, Beldjord C, Adjiman M, Kaplan JC (1993) Male infertility as the only presenting sign of cystic fibrosis when homozygous for the mild mutation R117H. J Med Genet 30: 797
Boat TF, Welsh MJ, Beaudet AL (1989) Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WE, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGraw-Hill, New York, pp 2649–2680
Chu CS, Trapnell BC, Murtagh Jr JJ, Moss J, Dalemans W, Jallat S, Mercenier A, Pavirani A, Lecocq JP, Cutting GR, Guggino WB, Crystal RG (1991) Variable deletions of exon 9 coding sequences in cystic fibrosis transmembrane regulator gene mRNA transcripts in normal bronchial epithelium. EMBO J 10: 1355–1363
Chu CS, Trapnell BC, Curristin S, Cutting GR, Crystal RG (1993) Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nature Genet 3: 151–156
Coltman CA Jr, Atwell RJ (1966) The electrolyte composition of normal adult sweat. Am Rev Respir Dis 93: 62–69
Culard JF, Desgeorges M, Costa P, Laussel M, Razakatzara G, Navratil H, Demaille J, Claustres M (1994a) Analysis of the whole CFTR coding regions and splice junctions in azoospermic men with congenital bilateral aplasia of epididymis or vas deferens. Hum Genet 93: 467–470
Culard JF, Desgeorges M, Romey MC, Malzac P, Demaille J, Claustres M (1994b) A novel splice site mutation in the first exon of the cystic fibrosis transmembrane regulator (CFTR) gene identified in a CBAVD patient. Hum Mol Genet 3: 369–370
Cuppens H, Teng H, Raeymaekers P, De Boek C, Cassiman JJ (1994) CFTR haplotypes backgrounds on normal and mutant CFTR genes. Hum Mol Genet 3: 607–614
Davis PB, Del Rio S, Muntz JA (1983) Sweat chloride concentration in adults with pulmonary disease. Am Rev Respir Dis 128: 34–37
Dumur V, Gervais R, Rigot JM, Lafitte JJ, Manouvrier S, Biserte J, Mazeman E, Roussel P (1990) Abnormal distribution of CF ΔF508 allele in azoospermic men with congenital aplasia of the epididymis and vas deferens. Lancet 336: 512
Gervais R, Dumur V, Rigot JM, Lafitte JJ, Roussel P, Claustres M, Demaille J (1993) High frequency of the R117H cystic fibrosis mutation in patients with congenital absence of the vas deferens. N Engl J Med 328: 446–447
Hall SK, Stableforth DE, Green A (1990) Sweat sodium and chloride concentrations — essential criteria for the diagnosis of cystic fibrosis in adults. Ann Clin Biochem 27: 318–320
Jequier AM, Ansell ID, Bullimore NJ (1985) Congenital absence of the vasa deferentia presenting with infertility. J Androl 6: 15–19
Kiesewetter S, Macek M Jr, Davis C, Curristin SM, Chu CS, Graham C, Shrimpton AE, Cashman SM, Tsui LC, Mickle J, Amos J, Highsmith WE, Shuber A, Witt DR, Crystal RG, Cutting GR (1993) A mutation in CFTR produces different phenotypes depending on chromosomal background. Nature Genet 5: 274–278
Kirk JM, Keston M, McIntosh I, Al Essa S (1992) Variation of sweat sodium and chloride with age in cystic fibrosis and normal populations: further investigations in equivocal cases. Ann Clin Biochem 29: 145–152
Meschede D, Eigel A, Horst J, Nieschlag E (1993) Compound heterozygosity for the ΔF508 and F508C cystic fibrosis transmembrane conductance regulator (CFTR) mutations in a patient with congenital bilateral aplasia of the vas deferens. Am J Hum Genet 53: 292–293
Oates RD, Amos JA (1994) The genetic basis of congenital bilateral absence of the vas deferens and Cystic Fibrosis. J Androl 15: 1–8
Osborne LR, Lynch M, Middleton PG, Alton EWFW, Geddes DM, Pryor JP, Hodson ME, Santis GK (1993) Nasal epithelial ion transport and genetic analysis of infertile men with congenital bilateral absence of the vas deferens. Hum Mol Genet 2: 1605–1609
Osborne LR, Alton EWFW, Tsui LC (1994) CFTR intron 8 poly-T tract length in men with congenital absence of the vas deferens. Pediatr Pulmonol [Suppl] 10: 214
Patrizio P, Asch RH, Handelin B, Silber SJ (1993a) Aetiology of congenital absence of vas deferens: genetic study of three generations. Hum Reprod 8: 215–222
Patrizio P, Ord T, Silber SJ, Asch RH (1993b) Cystic fibrosis mutations impair the fertilization rate of epididymal sperm from men with congenital absence of the vas deferens. Hum Reprod 8: 1259–1263
Rommens J, Kerem BS, Gree W, Chang P, Tsui LC, Ray P (1990) Rapid non radioactive detection of the major CF mutation. Am J Hum Genet 46: 395–396
Schales O, Schales SS (1941) A simple and accurate method for the determination of chloride in biological fluids. J Biol Chem 140: 879–881
Shwachman H (1962) The sweat test. Pediatrics 30: 167–171
Stern RC, Boat TF, Doershuk CF, Tucker AS, Mileer RB, Matthews LW (1977) Cystic Fibrosis diagnosed after age 13. Ann Intern Med 87: 188–191
Tsui LC (1992) Mutations and sequence variations detected in the Cystic Fibrosis conductance regulator (CFTR) gene: a report from the Cystic Fibrosis Genetic Analysis Consortium. Hum Mutat 1: 197–203
Zielinski J, Rozmahel R, Bozon D, Kerem B, Grzelczak Z, Riordan JR, Rommens JM, Tsui LC (1991) Genomic DNA sequences of the cystic fibrosis transmembrane regulator (CFTR) gene. Genomics 10: 214–228
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dumur, V., Gervais, R., Rigot, JM. et al. Congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis transmembrane regulator (CFTR): correlation between genotype and phenotype. Hum Genet 97, 7–10 (1996). https://doi.org/10.1007/BF00218824
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00218824